Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways
瑞戈非尼在体内和体外均能有效对抗神经母细胞瘤,并抑制 RAS/MAPK、PI3K/Akt/mTOR 和 Fos/Jun 通路
期刊:British Journal of Cancer
影响因子:6.4
doi:10.1038/s41416-020-0905-8
Divya Subramonian #, Nikki Phanhthilath #, Hannah Rinehardt, Sean Flynn, Yuchen Huo, Jing Zhang, Karen Messer, Qianxing Mo, Shixia Huang, Jacqueline Lesperance, Peter E Zage
信号转导
神经
其它细胞
WB
MAPK/ERK
Neuroscience
PI3K/Akt
mTOR